Therefore, potent inhibitors of human cytidine deaminase such as 1-beta-ribofuranosyl-1,3-diazepinone are potential treatment strategies in cancer patients as small molecule therapeutic adjuvants [46]. This evidence concerns the gene CDA and cancer.